COVID-19 Hutch News
Search and Filter
Results per Page:
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad
Sleuthing the immune system’s mysterious T-regs
Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research
HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor.
Researchers pinpoint 'correlates of protection' for Moderna vaccine
Findings may make it easier to test COVID-19 vaccine updates to protect against variants
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Q&A: Returning to school, post-transplant
As schools reopen for in-person learning, what should bone marrow transplant recipients do?
Ongoing trials test COVID-19 drugs for earlier, easier treatment
Injected monoclonal antibodies or oral antivirals could help more patients recover faster
Matsen, Bedford named Howard Hughes Medical Institute Investigators
Acclaimed computational biologists each awarded 7 years of funding
Science Says: Back to the future
Navigating work, school, and well-being in a world transformed by COVID-19
New concerns about coronavirus evolution in immunosuppressed patients
Experts call for tighter precautions, better treatments, more research
How studies of coronavirus immunity can inform better vaccines, treatments
Scientists look for broad-acting antibodies that could protect against new variants of SARS-CoV-2 — and maybe a future SARS-3
Deleted SARS-CoV-2 sequences from early in Wuhan outbreak offer clues
Detective work by Hutch evolutionary biologist reconstructs and analyzes data to provide evidence on pandemic origins
Catching up with cancer as COVID-19 starts to ebb
Public health researchers scramble to get preventive cancer screenings back on peoples’ radar – and calendars – as cases dwindle and restrictions lift
How RNA-altering drugs might improve anticancer immunotherapies
In lab study, brief disruptions of gene machinery make tumor cells more 'visible' to immune system
Understanding the origins of SARS-CoV-2
Hutch evolutionary biologist calls for more research on how COVID-19 pandemic started
Essential workers illustrate the Heart of the Hutch
While buildings remain more than half empty, hundreds of people keep science going and campus running amid pandemic
Addressing a 'massive unmet need' in COVID-19 treatment
COVID-19 Clinical Research Center tests drugs to reduce severe infections
Natural protection from COVID-19 gets boost from a single dose of vaccine
Tests of patients' blood show vaccine stirs antibodies against variants and 2003 SARS virus